Loading...
Time-series analysis in imatinib-resistant chronic myeloid leukemia K562-cells under different drug treatments
Chronic myeloid leukemia (CML) is characterized by the accumulation of active BCR-ABL protein. Imatinib is the first-line treatment of CML; however, many patients are resistant to this drug. In this study, we aimed to compare the differences in expression patterns and functions of time-series genes...
Na minha lista:
| Udgivet i: | J Huazhong Univ Sci Technolog Med Sci |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Huazhong University of Science and Technology
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7088819/ https://ncbi.nlm.nih.gov/pubmed/28786057 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11596-017-1781-1 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|